Skip to main content
Premium Trial:

Request an Annual Quote

NCI Earmarks $1M in SBIR Funding for Cancer Technology Projects

NEW YORK, Dec. 20 (GenomeWeb News) - The National Cancer Institute is setting aside roughly $1 million to fund three to five Phase I and Phase II Small Business Innovation Research and Small Business Technology Transfer cancer-technology development projects during 2006, according to the National Institutes of Health.

 

In a request for applications, the NIH said the NCI will fund projects focused on developing technologies suitable for the molecular analysis of cancers and their host environment in support of basic, clinical, and epidemiological research.

 

Examples of technologies and tools of interest under the RFA are ones for in vitro scanning for and identification of the sites of chromosomal aberrations which reflect inherited aberrations or somatic alterations resulting from aging or oxidation, or exposure to radiation or carcinogens, including those that are suitable for scaling for use across whole genomes, detecting DNA adducts, or detecting rare variants in mixed populations; technologies for detection and characterization of nucleic acid sequences of novel exogenous infectious agents that may be present in human cancer; and technologies to elucidate molecular modifications of macromolecules that may be indicative of and critical to the transformation process, said the NIH.

 

Letters of intent are due by Jan. 17, 2005; May 17, 2005; and Sept. 18, 2005. Applications are due Feb. 17, 2005; June 17, 2005; and Oct. 18, 2005. Additional information is available here.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.